Differential prognosis in AA patients who developed cytogenetic abnormalities.

(A) Cytogenetic evolution over the time within the group (30 patients = 100%). (B) Survival from the time of diagnosis (n = 30). (C) Survival from the time of evolution (n = 30). (D) Survival of patients with trisomy 8 (Tri-8; n = 7) and abnormalities of chromosome 7 (Mono-7; n = 11; P = .075).